Study Says Stem Cell ‘Fusion’ Occurs In Tumors
An Oregon Health & Science University study is adding credence to an increasingly popular theory that fusion is what bonds stem cells with bone marrow cells to regenerate organ tissue.
Engineered Functional Lung Tissue Grown on 3D Hydrogel
The engineered, 3-D pulmonary tissue constructs described in a report in the April 2006 issue of Tissue Engineering represent a successful first step in the creation of functional pulmonary tissue constructs designed for therapeutic use.
Researchers Differentiate Cord Blood Stem Cells into Alveolar Cells
BioE reported that scientists at the University of Minnesota, using its stem cell isolation technology, derived the company’s Multi-Lineage Progenitor Cell™ (MLPC) from cord blood and, for the first time, differentiated it into type II alveolar cells.
Isolating Adult Mesenchymal Stem Cells From Blood
Ortec International, Inc., a company focused on development and commercialization of products applicable to regenerative medicine and stem cell therapy, today announced the results of experiments showing the ability of Fibrin Microbeads (FMB), an advanced fibrin based biomaterial, to isolate the Mesenchymal class of adult stem cells (MSC) from human peripheral blood.
Austrianova Biotechnology Starts Industrial Production of NovaCaps
Austrianova today announced that it has started industrial production of its lead product NovaCaps®. Austrianova is the first company worldwide that has been successful in developing a market scale, GMP compliant, industrial production process for encapsulated cell products.
Cell Genesys Receives Fast Track Status for GVAX(R) Immunotherapy for Prostate Cancer
Cell Genesys, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for GVAX immunotherapy for prostate cancer, the company’s lead product candidate for the treatment of advanced prostate cancer.
M. D. Anderson Cancer Center Initiates Clinical Trial to Evaluate a Custom-Made Therapeutic Vaccine for the Treatment of Chronic Lymphocytic Leukemia
The University of Texas M. D. Anderson Cancer Center has initiated a clinical trial to evaluate the use of an idiotype active immunotherapy, also referred to as idiotype vaccine therapy, in patients with Chronic Lymphocytic Leukemia (CLL), a type of cancer affecting the blood and bone marrow.
Researchers Have Used Targeted Viral Vectors as Carriers to Attach Gold Nanoparticles to Tumors
This opens up the possibility of combining two types of treatment: heating the tumor using the gold nanoparticles, and killing the tumor using gene therapy.
Biovest’s AutovaxID(TM) Cleared for Commercial Sale; First and Only Device to Automate Production of Complex Biologics
A majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. , Biovest International, Inc., has been informed by the United States Food and Drug Administration (FDA) that its patent-pending AutovaxID(TM) device requires no further review by the FDA, allowing Biovest to commence commercialization of the device.
Therapy Helps Parkinson’s Patients
More than 1.5 million Americans suffer from Parkinson’s disease. There is no cure, but now there is a new treatment that may improve patients’ quality of life.
The South Korean Cloning Scientist Who Faked His Stem Cell Research Has Been Charged with Fraud and Embezzlement
Hwang Woo-suk was also charged with using millions of dollars in grants for private purposes, as well as violating laws on bio-ethics.
ABSTRACTS, REVIEWS & SPECIAL REPORTS
Bone Marrow-Derived Cells Fuse With Normal and Transformed Intestinal Stem Cells
The findings suggest an unexpected role for Bone Marrow-Dervied Stem Cells in both regeneration and tumorigenesis of the intestine.
Isolation of Mesenchymal Stem Cells from G-CSF-Mobilized Human Peripheral Blood Using Fibrin Microbeads
The study indicates that fibrin microbeads (FMB) may have special advantage in isolating mesenchymal stem cells (MSC) from sources such as mobilized PB, where the number of such cells is scarce.